Comparison of serum level of some trace elements and vitamin D between patients with premenstrual syndrome and normal controls: A cross-sectional study
Background: Premenstrual syndrome (PMS) is a common problem among women and is identified by reversal emotional, psychological, and physical signs during the luteal phase. These signs, however, lower down in the follicular phase. The cause of PMS isn’t very well-known up to now control group and many researchers have suggested that mineral compounds and vitamins can inhibit these symptoms.
Objective: The objective of this study is to compare the serum level of some trace elements and vitamin D between normal controls and patients with PMS.
Materials and Methods: 300 female students (19–21 yr old) from Falavarjan County were randomly selected and asked to complete a standard questionnaire on PMS during three menstruation cycles. The students were divided into two groups: healthy persons (control) and PMS persons, and PMS was determined on the basis of the answers to the questionnaire. Thereafter, the serum concentrations of zinc, iron, calcium, magnesium, potassium, sodium, and Vitamin D3 were measured and compared between the two groups.
Results: Our results showed that the PMS prevalence was about 41.5%. The level of vitamin D decreased in both the control and PMS groups, with a significantly lower range of vitamin D (p 0.05) in the PMS group. Other factors had no significant change between the two groups.
Conclusion: Vitamin D deficiency was probably one of the most important causes of unpleasant symptoms of PMS between these students.
Key words: Premenstrual syndrome, Trace elements, Vitamin D.
 Zaka M, Mahmood KT. Pre-menstrual syndrome-a review. J Pharm Sci Res 2012; 4: 1684–1691.
 Stoner R, Camilleri V, Calleja-Agius J, Schembri-Wismayer P. The cytokine-hormone axisthe link between premenstrual syndrome and postpartum depression. Gynecol Endocrinol 2017; 33: 588–592.
 Speroof L, Fritz M. Clinical gynecology endocrinology and infertility. 7th Ed. Philadelphia; Lippincott Williams & Wilkins; 2005.
 Hariri FZ, Moghaddam-Banaem L, SiahBazi S, Saki Malehi A, Montazeri A. The Iranian version of the premenstrual symptoms screening tool (PSST): a validation study. Arch Womens Ment Health 2013; 16: 531–537.
 Farokh-Eslamlou HR, Nabilou B, Oshnoee S, Akbari E. [The prevalence of premenstrual syndrome and its associated factors among medical students of Urmia University of medical sciences.] J Urmia Univ Med Sci 2013; 24: 702–710. (in Persian).
 Ozgoli G, Selselei E, AlaviMajd H. [Severity of premenstrual syndrome and its related factors in students of ShahidBeheshti University of medical sciences.] Advances in Nursing & Midwifery 2010; 20: 1–5. (in Persian).
 Talaei A, Fayyazi Bordbar MR, Nasiraei A, Dadgar S, Samari A. [Epidemiology of premenstrual syndrome (PMS) in Students of Mashhad University of Medical Science]. Iran J Obstet Gynecol Infertil 2009; 12: 15–22. (in Persian).
 Direkvand-Moghadam A, Saeyhmiri K, Delpisheh A, Kaikhavandi S. Epidemiology of premenstrual syndrome (PMS) - a systematic review and meta-analysis study. J Clin Diagn Res 2014; 8: 106–109.
 Qiao M, Zhang H, Liu H, Luo S, Wang T, Zhang J, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. Eur J Obstet Gynecol Reprod Biol 2012; 162: 83–86.
 Sarkar AP, Mandal R, Ghorai S. Premenstrual syndrome among adolescent girl studentsin a rural school of West Bengal, India. Int J Med Sci Public Health 2016; 5: 408–411.
 Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Clin Nutr 1988; 47: 636–641.
 Saeediankia A, Amani R, Cheraghian B. The Association between the risk of premenstrual syndrome and vitamin D, calcium, and magnesium status among University Students: A case control study. Health Promot Perspect 2015; 5: 225–230.
 Fathizadeh S, Amani R, Haghighizadeh MH, Hormozi R. Comparison of serum zinc concentrations and body antioxidant status between young women with premenstrual syndrome and normal controls: A case-control study. Int J Reprod Biomed 2016; 14: 699–704.
 Shamberger RJ. Calcium, magnesium, and other elements in the red blood cells and hair of normals and patients with premenstrual syndrome. Biol Trace Elem Res 2003; 94: 123–129.
 Chocano-Bedoya PO, Manson JE, Hankinson SE, Johnson SR, Chasan-Taber L, Ronnenberg AG, et al. Intake of selected minerals and risk of premenstrual syndrome. Am J Epidemiol 2013; 177: 1118–1127.
 Stewart A. Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 1987; 32: 435–441.
 Lovick TA, Guapo VG, Anselmo-Franci JA, Loureiro CM, Faleiros MCM, Del Ben CM, et al. A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms. Psychoneuroendocrinology 2017; 75: 83–90.
 Rajaei S, AkbariSene A, Norouzi S, Berangi Y, Arabian S, Lak P, et al. The relationship between serum vitamin D level and premenstrual syndrome in Iranian women. Int J Reprod Biomed 2016; 14: 665–668.
 Dadkhah H, Ebrahimi E, Fathizadeh N. Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome: A randomized, double-blind, controlled trial. Iran J Nurs Midwifery Res 2016; 21: 159–164.
 Khajehei M, Abdali K, Parsanezhad ME, Tabatabaee HR. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. Int J Gynaecol Obstet 2009; 105: 158–161.
 Obeidat BA, Alchalabi HA, Abdul-Razzak KK, Al-Farras MI. Premenstrual symptoms in dysmenorrheic college students: prevalence and relation to vitamin D and parathyroid hormone levels. Int J Environ Res Public Health 2012; 9: 4210–4222.
 Bertone-Johnson ER, Hankinson SE, Forger NG, Powers SI, Willett WC, Johnson SR, et al. Plasma 25-hydroxy vitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health 2014; 14: 56.
 Groves NJ, McGrath JJ, Burne TH. Vitamin D as a neurosteroid affecting the developing and adult brain. Ann Rev Nutr 2014; 34: 117–141.
 Bertone-Johnson ER, Ronnenberg AG, Houghton SC, Nobles C, Zagarins SE, Takashima-Uebelhoer BB, et al. Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women. Hum Reprod 2014; 29: 1987–1994.
 Rajaei S, Dabbagh A. The molecular mechanisms of Vitamin D effects on alleviating premenstrual syndrome pain. J Cell Mol Anesth 2017; 2: 30–36.
 Gu¨ lec¸Ylmaz S, Gu¨ l T, Attar R, Yıldırım G, PIs¸bir T. Association between fok1 polymorphism of vitamin D receptor gene with uterine leiomyoma in Turkish populations. J Turk Ger Gynecol Assoc 2018; 19: 128–131.
 Dasgupta S, Dutta J, Annamaneni S, Kudugunti N, Battini MR. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women. Indian J Med Res 2015; 142: 276–285.
 Hussain S, Hussain S, Abdraboh NR. Vitamin D receptor Fok1 polymorphism and its relationship with premenstrual syndrome. Gene Reports 2018; 12: 324–328.
 Ahmadi S, Mirzaei K, Hossein-Nezhad A, Shariati G. Vitamin D receptor FokI genotype may modify the susceptibility to schizophrenia and bipolar mood disorderby regulation of dopamine D1 receptor gene expression. Minerva Med 2012; 103: 383–391.
 Glocke M, Lang F, Schaeffeler E, Lang T, Schwab M, Lang UE. Impact of vitamin D receptor VDR rs2228570 polymorphism in oldest old. Kidney Blood Press Res 2013; 37: 311–322.